Skip to main content
SpringerLink
Log in

Le peptide natriurétique atrial (ANP)

  • Chapter
Book cover Les biomarqueurs en médecine d’urgence

Part of the book series: Références en médecine d’urgence. Collection de la SFMU ((REFERMED))

  • 647 Accesses

Résumé

Les peptides natriurétiques de type B sont parmi les plus étudiés et les plus utilisés des biomarqueurs actuellement à la disposition du clinicien. Un récent regain d’intérêt pour le peptide natriurétique atrial (ou Atrial Natriuretic Peptide, ANP) a soulevé la question de la place potentielle de ce marqueur dans léarsenal diagnostique de l’insuffisance cardiaque.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. de Bold A (1985) Atrial natriuretic factor: a hormone produced by the heart. Science 230: 767–770

    Article  PubMed  Google Scholar 

  2. Scott NJ, Ellmers LJ, Lainchbury JG, et al. (2009) Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. Biochim Biophys Acta 1792: 1175–1184

    Article  PubMed  CAS  Google Scholar 

  3. Suttner SW, Boldt J (2004) Natriuretic peptide system: physiology and clinical utility. Curr Opin Crit Care 10: 336–341

    Article  PubMed  Google Scholar 

  4. Jourdain P, Lefèvre G, Oddoze C, et al. (2009) [NT-proBNP In practice: from chemistry to medicine]. Ann Biol Clin 67: 255–271

    CAS  Google Scholar 

  5. Vesely DL (2002) Atrial natriuretic peptide prohormone gene expression: hormones and diseases that upregulate Its expression. IUBMB Life 53: 153–159

    Article  PubMed  CAS  Google Scholar 

  6. Vollmar AM, Schulz R (1995) Expression and differential regulation of natriuretic peptides In mouse macrophages. J Clin Invest 95:2442–2450

    Article  PubMed  CAS  Google Scholar 

  7. Ruskoaho H (2003) Cardiac hormones as diagnostic tools In heart failure. Endocr Rev 24: 341–356

    Article  PubMed  CAS  Google Scholar 

  8. Buckley MG, Marcus NJ, Yacoub MH (1999) Cardiac peptide stability, aprotinin and room temperature: Importance for assessing cardiac function in clinical practice. Clin Sci 97: 689–695

    Article  PubMed  CAS  Google Scholar 

  9. Morgenthaler NG, Struck J, Thomas B, Bergmann A (2004) Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide In human plasma. Clin Chem 50: 234–236

    Article  PubMed  CAS  Google Scholar 

  10. Gegenhuber A, Struck J, Poelz W, et al. (2006) Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal pro-BNP. Clin Chem 52: 827–831

    Article  PubMed  CAS  Google Scholar 

  11. Von Haehling S, Jankowska EA, Morgenthaler NG, et al. (2007) Comparison of Midregional Pro-Atrial Natrluretlc Peptide With N-Terminal Pro-B-Type Natrluretlc Peptide In Predicting Survival In Patients With Chronic Heart Failure. J Am Coll Cardiol 50: 1973–1980

    Article  Google Scholar 

  12. Dieplinger B, Januzzi JL Jr, Steinmair M, et al. (2009) Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 In human plasma—the Presage ST2 assay. Clin Chim Acta 409: 33–40

    Article  PubMed  CAS  Google Scholar 

  13. Potocki M, Breidthardt T, Reichlin T, et al. (2010) Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretlc peptide In the diagnosis of heart failure. J Intern Med 267: 119–129

    Article  PubMed  CAS  Google Scholar 

  14. Maisel A, Mueller C, Nowak R, et al. (2010) Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers In Acute Heart Failure) trial. J Am Coll Cardlol 55: 2062–2076

    Article  CAS  Google Scholar 

  15. Chenevier-Gobeaux C, Guerin S, André S, et al. (2010) Mid-Regional pro-Atrial Natrluretlc Peptide for the Diagnosis of Cardiac-Related Dyspnea According to Renal Function in the Emergency Department: A Comparison with B-Type Natrluretlc Peptide (BNP) and N-Terminal pro-BNP. Clin Chem 56: 1708–1717

    Article  PubMed  CAS  Google Scholar 

  16. Guinard-Barbier S, Grabar S, Chenevier-Gobeaux C, et al. (2011) Is Mid Regional pro-Atrial Natriuretlc Peptide (MRproANP) an Accurate Marker of Bacteraemia in Pyelonephritis? Biomarkers 16: 355–363

    Article  PubMed  CAS  Google Scholar 

  17. Morgenthaler NG, Struck J, Christ-Crain M, et al. (2005) Pro-atrial natriuretic peptide Is a prognostic marker In sepsis, similar to the APACHE II score: an observational study. Critical Care 9: R37–45

    Article  PubMed  Google Scholar 

  18. Claessens YE, Mathevon T, Kierzek G, et al. (2010) Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia. Int Care Med 36: 799–809

    Article  CAS  Google Scholar 

  19. Prat C, Lacoma A, Dominguez J, et al. (2007) Midregional pro-atrial natriuretic peptide as a prognostic marker In pneumonia. J Infect 55: 400–477

    Article  PubMed  Google Scholar 

  20. Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T; CAPNETZ Study Group (2010) Pro-atrial natrluretlc peptide and pro-vasopressin for predicting short-term and long-term survical in community-acquired pneumonia: results from the German Competence Network CAPNETZ. Thorax 65: 208–214

    Article  PubMed  Google Scholar 

  21. Masiá M, Papassotiriou J, Morgenthaler NG, et al. (2007) Midregional Pro-A-Type Natriuretic peptide and Carboxy-Terminal Provasopressin may predict prognosis in community-acquired pneumonia. Clin Chem 53: 2193–2201

    Article  PubMed  Google Scholar 

  22. Burger AJ, Horton DP, LeJemtel T, et al. (2002) Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J 144: 1102–1108

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. département de médecine d’urgence, Centre hospitalier Princesse Grace, 1, avenue Pasteur, BP 489, MC-98012, Monaco

    Y.-É. Claessens

  2. Service des urgences, Groupe hospitalier Broca Cochin Hôtel-Dieu, Université Paris-Descartes, 27, rue du Faubourg-Saint-Jacques, 75679, Paris Cedex 14, France

    A. Eche

Authors
  1. Y.-É. Claessens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Eche
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Département de médecine d’urgence, Centre hospitalier Princesse Grace, 1, avenue Pasteur, BP 489, MC-98012, Monaco

    Yann-Érick Claessens

  2. Hôpital Tenon Service d’accueil des urgences, UPMC-Paris 6, 4, rue de la Chine, 75020, Paris, France

    Patrick Ray

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Claessens, YÉ., Eche, A. (2012). Le peptide natriurétique atrial (ANP). In: Claessens, YÉ., Ray, P. (eds) Les biomarqueurs en médecine d’urgence. Références en médecine d’urgence. Collection de la SFMU. Springer, Paris. https://doi.org/10.1007/978-2-8178-0297-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0297-8_10

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0296-1

  • Online ISBN: 978-2-8178-0297-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation